CA74346M4065 - Common Stock
PROMIS NEUROSCIENCES INC
NASDAQ:PMN (9/6/2024, 8:00:00 PM)
After market: 1.29 -0.01 (-0.78%)1.3001
-0.07 (-5.02%)
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. The company is headquartered in Toronto, Ontario and currently employs 6 full-time employees. The company went IPO on 2017-04-03. The firm is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The firm plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.
PROMIS NEUROSCIENCES INC
Suite 200, 1920 Yonge Street
TORONTO ONTARIO
P: 14168476898
Employees: 6
Website: https://www.promisneurosciences.com/
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Sept. 05, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company...
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
PMN stock results show that ProMIS Neurosciences beat analyst estimates for earnings per share the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ProMIS Neurosciences (NASDAQ:PMN) just reported results for the second quarter ...
Here you can normally see the latest stock twits on PMN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: